Astrazeneca PLC, 10% Owner at Entasis Therapeutics Holdings Inc. (ETTX), bought 2,164,851 shares at $15.00 ($3.7M) on 2018-09-28, disclosed to the SEC on 2018-10-02.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 1,918,185 | $0 | 0.0% |
| 2 | $15.00 | 246,666 | $3.7M | 100.0% |
| Total | $1.71 avg | 2,164,851 | $3.7M | 100% |
| Filing → |